tiprankstipranks
Trending News
More News >
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
US Market

Sarepta Therapeutics (SRPT) Income Statement

Compare
4,044 Followers

Sarepta Therapeutics Income Statement

Last quarter (Q3 2025), Sarepta Therapeutics's total revenue was $399.36M, a decrease of -14.52% from the same quarter last year. In Q3, Sarepta Therapeutics's net income was $-179.95M. See Sarepta Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.90B$ 1.24B$ 933.01M$ 701.89M$ 540.10M
Gross Profit
$ 1.58B$ 1.09B$ 793.02M$ 604.84M$ 476.72M
Operating Expenses
$ 1.36B$ 1.36B$ 1.33B$ 1.06B$ 1.04B
Depreciation and Amortization
$ 53.89M$ 58.89M$ 54.60M$ 38.02M$ 39.74M
EBITDA
$ 333.06M$ -439.20M$ -582.12M$ -317.41M$ -453.38M
Operating Income
$ 218.08M$ -267.82M$ -536.20M$ -459.71M$ -564.16M
Other Income/Expenses
$ 42.69M$ -252.27M$ -153.76M$ 40.76M$ 11.10M
Pretax Income
$ 260.77M$ -520.10M$ -689.96M$ -418.95M$ -553.07M
Net Income
$ 235.24M$ -535.98M$ -703.49M$ -418.78M$ -554.13M
Per Share Metrics
Basic EPS
$ 2.47$ -5.80$ -8.03$ -5.15$ -7.11
Diluted EPS
$ 2.34$ -5.80$ -8.03$ -5.15$ -7.11
Weighted Average Shares Outstanding
95.08M 92.40M 87.56M 81.26M 77.96M
Weighted Average Shares Outstanding (Diluted)
107.88M 92.40M 87.56M 81.26M 77.96M
Currency in USD

Sarepta Therapeutics Earnings and Revenue History